NCT07042620 2026-04-16
A Study to Test a New Fluid to Improve the Quality of Images Obtained by Using Sound Waves (Ultrasound) During Surgery
SonoClear AS
Phase NA Recruiting
Clinical Trials
22 trialsNCT04988750 2026-04-13
Evaluate the Safety and Preliminary Efficacy of the Combination of NaviFUS System With Re-irradiation for rGBM Patients
NaviFUS Corporation
Phase NA Completed
NCT04446416 2026-04-09
Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients
NaviFUS Corporation
Phase NA Completed
NCT06910306 2026-04-06
Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma
Alpha Tau Medical LTD.
Phase NA Recruiting
NCT04471844 2026-03-30
EF-32
NovoCure Ltd.
Phase NA Completed
NCT03551249 2026-03-20
Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption
InSightec
Phase NA Completed
NCT07274397 2025-12-10
EARLYBRAINPET
Beta Emitting Accurate Monitored Systems
Phase NA Not yet recruiting
NCT05383872 2025-07-28
Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors
InSightec
Phase NA Completed
NCT06533163 2025-07-14
OMX-EFS-01
BioTex, Inc.
Phase NA Recruiting
NCT04734444 2025-06-17
SonoClear Acoustic Coupling Fluid (ACF) Mimicking Brain Tissue
SonoClear AS
Phase NA Completed
NCT03717142 2025-01-15
Feasibility of the LUM Imaging System for Detection of Cancer to the Brain
Lumicell, Inc.
Phase NA Terminated
NCT05296122 2025-01-15
Safety and Feasibility of MR-guided Laser Thermal Ablation of Brain Lesions
Clinical Laserthermia Systems AB
Phase NA Completed
NCT03712293 2024-03-05
ExAblate Blood-Brain Barrier Disruption for Glioblastoma in Patients Undergoing Standard Chemotherapy
InSightec
Phase NA Completed
NCT03616860 2024-01-23
Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption for Treatment of Glioma
InSightec
Phase NA Completed
NCT02296580 2023-02-02
A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM)
Nativis, Inc.
Phase NA Completed
NCT03276286 2023-02-02
NAT109
Nativis, Inc.
Phase NA Completed
NCT03322813 2022-08-03
ExAblate Blood Brain Barrier Disruption (BBBD) for Planned Surgery in Suspected Infiltrating Glioma
InSightec
Phase NA Suspended
NCT04717999 2021-01-22
Pilot Study of NKG2D CAR-T in Treating Patients With Recurrent Glioblastoma
UWELL Biopharma
Phase NA Unknown
NCT03626896 2019-06-21
Safety of BBB Disruption Using NaviFUS System in Recurrent Glioblastoma Multiforme (GBM) Patients
NaviFUS Corporation
Phase NA Completed
NCT03780569 2018-12-20
TTFields Together With Temozolomide and Radiotherapy in Patients With Newly Diagnosed GBM
NovoCure Ltd.
Phase NA Unknown
NCT02507102 2018-03-30
A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM) in Australia
Nativis, Inc.
Phase NA Completed
NCT01637753 2012-07-11
Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma
Shandong Lanjin Pharmaceuticals Co.,Ltd
Phase NA Unknown